Red Journal Podcast July 1, 2023: Genomic Classifiers in Prostate Cancer Critical or Optional?
b'Genitourinary Section Editor Alison Tree, Consultant Clinical Oncologist at the Royal Marsden NHS Foundation Trust, hosts a discussion this month on genomic classifiers in prostate cancer. Guests are Paul Nguyen, Vice-Chair for Clinical Research and Genitourinary Disease Center Leader at the Brigham and Women\\u2019s Hospital\'s Department of Radiation Oncology and first author of "Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials"; Neil Desai, Associate Professor and Director of Clinical Research in the Department of Radiation Oncology at UT Southwestern Medical Center and first author of "Passing the Kool-Aid Point: mRNA Expression-Based Risk Classifiers in Localized Prostate Cancer Treatment Decision Making"; and Simon Spohn, Resident in the Department of Radiation Oncology at the University Medical Center Freiburg and first author of "Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus".'